Search
for
Sort by
Research 30 of 1000+
- The JAK/STAT signaling pathway: from bench to clinic
- The Use of Janus Kinase Inhibitors in Alopecia Areata: A Review of the Literature
- The role of janus kinases in the treatment of autoimmune skin diseases
- Janus kinase (JAK) inhibitors for the treatment of skin and hair disorders: a review of literature
- Janus Kinase Inhibitors in Dermatology: Part 1 — General Considerations and Applications in Vitiligo and Alopecia Areata
- Efficacy, Safety, and Real-World Aspects of Janus Kinase Inhibitors to Treat Patients With Alopecia Areata
- Janus Kinase Inhibitors - A next generation treatment in Dermatology
- Comparative efficacy of oral Janus kinase inhibitors and biologics in adult alopecia areata: A systematic review and Bayesian network meta‐analysis
- Dermal T cell immunity and key regulatory signaling pathways: Implications in immune-mediated alopecia and hair regeneration
- Hair growth–promoting effects of Enz_MoriL on human dermal papilla cells through modulation of the Wnt/β-Catenin and JAK-STAT signaling pathways
- Chemotherapy-Induced Alopecia Beyond Cytotoxicity: Hair Follicle Immune Privilege Collapse and JAK-STAT Signaling
- Precision therapeutics in non-scarring alopecia: a systemic genomic and pathway-based framework for targeted interventions
- An Overview about Alopecia Areata Etiopathogenesis, Diagnosis, and Management: Review Article
- Successful treatment of coexisting alopecia areata and hidradenitis suppurativa with upadacitinib
- Use of Jak Inhibitors in the Treatment of Alopecia Areata
- Considerations for the Treatment Strategy of Relapse After Tofacitinib Therapy in Alopecia Areata
- The Role of JAK Inhibitors in Atopic Dermatitis, Alopecia Areata, and Vitiligo: A Review article
- Farmácia Padrão da Légua, Custóias e nos Serviços Farmacêuticos da Klinicka Bolnica Dubrava, Croácia
- Functional Interpretation of Genome-Wide Association Study Evidence in Alopecia Areata
- FDA approval of Deuruxolitinib: A New Treatment Option for Severe Alopecia Areata
- New drugs under investigation for the treatment of alopecias
- Baricitinib for Alopecia Universalis Following Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms
- Clinical evidence for JAK inhibition in alopecia areata: A comprehensive review
- A Concise Review on Novel Drugs Applied in Treatment of Alopecia
- Topical metformin as a novel therapy for alopecia areata due to its immunologic effects
- Alopecia areata – Current understanding and management
- Brazilian Experience of the Treatment of Alopecia Universalis with the Novel Antirheumatic Therapy Tofacitinib: A Case Series
- 59 Scarring alopecia is driven by the collapse of EGFR-protected JAK-STAT1-sensitive stem cell immune privilege
- Two Birds that Exclude Each Other: The Renbök Phenomenon
- The emerging role of Janus kinase inhibitors in the treatment of autoimmune and inflammatory diseases